| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| YI111, Inc. | 28.99M | 5.72 | -0.76 | -3.66% | -0.52% | -22.96% | 100% | 0.67 |
| HITIHigh Tide Inc. | 218.65M | 2.51 | -46.06 | 7.1% | -1.76% | -6.82% | 11.8% | 0.51 |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 873.84M | 959.49M | 1.79B | 3.95B | 8.2B | 12.43B | 13.52B | 14.95B | 14.4B |
| Revenue Growth % | - | 0.1% | 0.86% | 1.21% | 1.08% | 0.51% | 0.09% | 0.11% | -0.04% |
| Cost of Goods Sold | 796.23M | 868.72M | 1.68B | 3.79B | 7.84B | 11.8B | 12.68B | 14.5B | 13.57B |
| COGS % of Revenue | 0.91% | 0.91% | 0.94% | 0.96% | 0.96% | 0.95% | 0.94% | 0.97% | 0.94% |
| Gross Profit | 77.61M | 90.77M | 104.27M | 165.18M | 365.83M | 621.1M | 839.98M | 448.44M | 829.23M |
| Gross Margin % | 0.09% | 0.09% | 0.06% | 0.04% | 0.04% | 0.05% | 0.06% | 0.03% | 0.06% |
| Gross Profit Growth % | - | 0.17% | 0.15% | 0.58% | 1.21% | 0.7% | 0.35% | -0.47% | 0.85% |
| Operating Expenses | 441.89M | 344.79M | 504.64M | 658.7M | 839.14M | 1.26B | 1.21B | 798.54M | 827.12M |
| OpEx % of Revenue | 0.51% | 0.36% | 0.28% | 0.17% | 0.1% | 0.1% | 0.09% | 0.05% | 0.06% |
| Selling, General & Admin | 443.88M | 347.52M | 503.98M | 654.96M | 527.84M | 720.13M | 663.5M | 672.59M | 384.8M |
| SG&A % of Revenue | 0.51% | 0.36% | 0.28% | 0.17% | 0.06% | 0.06% | 0.05% | 0.04% | 0.03% |
| Research & Development | 61.77M | 48.13M | 71.25M | 61.9M | 92.08M | 189.28M | 139.5M | 0 | 0 |
| R&D % of Revenue | 0.07% | 0.05% | 0.04% | 0.02% | 0.01% | 0.02% | 0.01% | - | - |
| Other Operating Expenses | -3.35M | 4.23M | 11.53M | -58.17M | 219.23M | 353.82M | 407.97M | 125.95M | 442.31M |
| Operating Income | -364.28M | -254.02M | -400.38M | -493.51M | -473.31M | -642.14M | -371M | -350.1M | 2.11M |
| Operating Margin % | -0.42% | -0.26% | -0.22% | -0.12% | -0.06% | -0.05% | -0.03% | -0.02% | 0% |
| Operating Income Growth % | - | 0.3% | -0.58% | -0.23% | 0.04% | -0.36% | 0.42% | 0.06% | 1.01% |
| EBITDA | -352.22M | -239.2M | -389.11M | -481.85M | -459.29M | -614.92M | -330.18M | -328.32M | 19.08M |
| EBITDA Margin % | -0.4% | -0.25% | -0.22% | -0.12% | -0.06% | -0.05% | -0.02% | -0.02% | 0% |
| EBITDA Growth % | - | 0.32% | -0.63% | -0.24% | 0.05% | -0.34% | 0.46% | 0.01% | 1.06% |
| D&A (Non-Cash Add-back) | 12.06M | 14.82M | 11.27M | 11.67M | 14.02M | 27.22M | 40.82M | 21.78M | 16.97M |
| EBIT | -362.69M | -249.27M | -400.38M | -498.2M | -473.31M | -615.54M | -362.63M | -333.04M | 7.65M |
| Net Interest Income | 1.56M | 3.96M | 4.35M | 1.18M | -2.5M | 4.29M | -5.33M | -11.31M | -21.29M |
| Interest Income | 2.31M | 4.01M | 4.35M | 4.8M | 6.31M | 9.78M | 8.12M | 8.83M | 7.04M |
| Interest Expense | 751K | 55K | 0 | 3.62M | 8.82M | 5.49M | 13.44M | 20.14M | 28.33M |
| Other Income/Expense | 834K | 4.7M | 18.34M | -8.31M | 6.2M | 21.11M | -5.07M | -3.08M | -22.79M |
| Pretax Income | -363.45M | -249.33M | -382.03M | -501.83M | -467.11M | -621.02M | -376.07M | -353.18M | -20.68M |
| Pretax Margin % | -0.42% | -0.26% | -0.21% | -0.13% | -0.06% | -0.05% | -0.03% | -0.02% | -0% |
| Income Tax | -3.37M | 0 | 8K | 0 | 0 | 0 | 0 | 251K | 96K |
| Effective Tax Rate % | 1% | 1% | 0.99% | 1% | 0.98% | 1.08% | 1.11% | 1.11% | 3.13% |
| Net Income | -362.68M | -248.58M | -380.09M | -501.83M | -456.53M | -669.81M | -416.88M | -392.69M | -64.74M |
| Net Margin % | -0.42% | -0.26% | -0.21% | -0.13% | -0.06% | -0.05% | -0.03% | -0.03% | -0% |
| Net Income Growth % | - | 0.31% | -0.53% | -0.32% | 0.09% | -0.47% | 0.38% | 0.06% | 0.84% |
| Net Income (Continuing) | -363.45M | -249.33M | -382.04M | -501.83M | -467.11M | -621.02M | -376.07M | -353.43M | -20.78M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 2.19M | 1.44M | -512K | -2.73M | 973.24M | 1.02B | 1.06B | 859.55M | 1.02B |
| EPS (Diluted) | -100.74 | -69.04 | -76.44 | -60.16 | -55.40 | -80.76 | -50.04 | -46.58 | -7.52 |
| EPS Growth % | - | 0.31% | -0.11% | 0.21% | 0.08% | -0.46% | 0.38% | 0.07% | 0.84% |
| EPS (Basic) | -116.10 | -69.04 | -76.44 | -60.16 | -55.40 | -80.76 | -50.04 | -46.58 | -7.52 |
| Diluted Shares Outstanding | 3.6M | 3.6M | 4.97M | 8.18M | 8.24M | 8.29M | 8.33M | 8.43M | 8.62M |
| Basic Shares Outstanding | 3.12M | 3.6M | 4.97M | 8.18M | 8.24M | 8.29M | 8.33M | 8.43M | 8.62M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 900.81M | 730.47M | 1.51B | 1.48B | 2.87B | 2.8B | 3.24B | 2.93B | 2.65B |
| Cash & Short-Term Investments | 640.33M | 461.19M | 1.11B | 613.75M | 1.49B | 843.95M | 879.53M | 653.67M | 462.29M |
| Cash Only | 373.5M | 167.66M | 853.74M | 613.75M | 1.19B | 661.39M | 673.67M | 603.52M | 462.29M |
| Short-Term Investments | 266.82M | 293.53M | 252.81M | 0 | 300.17M | 182.56M | 205.86M | 50.14M | 0 |
| Accounts Receivable | 28.39M | 20.4M | 87.4M | 88.83M | 175.68M | 495.2M | 600.49M | 647.48M | 630.72M |
| Days Sales Outstanding | 11.86 | 7.76 | 17.86 | 8.2 | 7.82 | 14.55 | 16.22 | 15.81 | 15.99 |
| Inventory | 134.73M | 144.06M | 210.84M | 486.27M | 766.53M | 1.12B | 1.5B | 1.42B | 1.39B |
| Days Inventory Outstanding | 61.76 | 60.53 | 45.76 | 46.87 | 35.7 | 34.66 | 43.16 | 35.73 | 37.31 |
| Other Current Assets | 97.36M | 102.93M | 156.11M | 285.33M | 432.59M | 332M | 250.25M | 206.88M | 62.82M |
| Total Non-Current Assets | 40.8M | 32.92M | 39.32M | 128.86M | 153.78M | 344.1M | 237.99M | 155.71M | 138.09M |
| Property, Plant & Equipment | 24.49M | 17.03M | 20.3M | 117.69M | 142.07M | 314.1M | 212.37M | 138.14M | 121.97M |
| Fixed Asset Turnover | 35.68x | 56.35x | 87.97x | 33.58x | 57.74x | 39.56x | 63.65x | 108.21x | 118.07x |
| Goodwill | 0 | 0 | 0 | 0 | 5.6M | 0 | 0 | 0 | 0 |
| Intangible Assets | 5.31M | 4.75M | 4.5M | 8.02M | 920K | 4.91M | 3.27M | 2.26M | 1.44M |
| Long-Term Investments | 11M | 11.14M | 11.14M | 140K | 140K | 3M | 2M | 2M | 0 |
| Other Non-Current Assets | 0 | 0 | 3.38M | 3.01M | 5.06M | 22.09M | 20.35M | 13.31M | 14.68M |
| Total Assets | 941.61M | 763.38M | 1.55B | 1.61B | 3.03B | 3.15B | 3.47B | 3.09B | 2.79B |
| Asset Turnover | 0.93x | 1.26x | 1.15x | 2.45x | 2.71x | 3.95x | 3.89x | 4.84x | 5.17x |
| Asset Growth % | - | -0.19% | 1.03% | 0.04% | 0.88% | 0.04% | 0.1% | -0.11% | -0.1% |
| Total Current Liabilities | 172.15M | 201.16M | 314.52M | 745.63M | 1.63B | 2.13B | 2.73B | 2.75B | 2.34B |
| Accounts Payable | 97.98M | 128.14M | 212.26M | 444.33M | 1.07B | 1.35B | 1.76B | 1.59B | 1.72B |
| Days Payables Outstanding | 44.92 | 53.84 | 46.07 | 42.83 | 49.99 | 41.66 | 50.82 | 39.99 | 46.3 |
| Short-Term Debt | 0 | 0 | 0 | 95.08M | 229.25M | 259.66M | 178.99M | 338.07M | 160.98M |
| Deferred Revenue (Current) | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Liabilities | 32.32M | 37.66M | 50.68M | -7.12M | 67.03M | 69.29M | 190.54M | 504.16M | 90.5M |
| Current Ratio | 5.23x | 3.63x | 4.79x | 1.99x | 1.76x | 1.32x | 1.19x | 1.07x | 1.13x |
| Quick Ratio | 4.45x | 2.92x | 4.12x | 1.33x | 1.29x | 0.79x | 0.64x | 0.55x | 0.54x |
| Cash Conversion Cycle | 28.7 | 14.45 | 17.55 | 12.25 | -6.47 | 7.55 | 8.56 | 11.55 | 7 |
| Total Non-Current Liabilities | 193.93M | 243.41M | 8.13M | 90.74M | 66.12M | 167.15M | 100.47M | 67.87M | 64.41M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 57.01M | 62.39M | 165.61M | 100.47M | 62.62M | 55.45M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 193.93M | 243.41M | 8.13M | 5.94M | 3.74M | 1.54M | 0 | 5.25M | 8.96M |
| Total Liabilities | 366.08M | 444.56M | 322.65M | 836.37M | 1.7B | 2.3B | 2.83B | 2.81B | 2.41B |
| Total Debt | 0 | 0 | 0 | 208.76M | 329.35M | 491.01M | 344.19M | 443.23M | 256.77M |
| Net Debt | -373.5M | -167.66M | -853.74M | -461.65M | -860.27M | -170.38M | -329.48M | -160.29M | -205.52M |
| Debt / Equity | - | - | - | 0.27x | 0.25x | 0.58x | 0.53x | 1.61x | 0.67x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | 13.46x |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | -10.77x |
| Interest Coverage | -485.06x | -4618.58x | - | -136.25x | -53.68x | -117.01x | -27.60x | -17.38x | 0.07x |
| Total Equity | 575.52M | 318.82M | 1.22B | 773.92M | 1.33B | 848.71M | 648.24M | 276.1M | 380.76M |
| Equity Growth % | - | -0.45% | 2.84% | -0.37% | 0.72% | -0.36% | -0.24% | -0.57% | 0.38% |
| Book Value per Share | 159.87 | 88.56 | 246.10 | 94.57 | 161.50 | 102.34 | 77.80 | 32.75 | 44.19 |
| Total Shareholders' Equity | 573.34M | 317.38M | 1.22B | 776.66M | 357.4M | -173.32M | -414.6M | -583.45M | -642.64M |
| Common Stock | 25K | 25K | 54K | 55K | 55K | 56K | 56K | 57K | 58K |
| Retained Earnings | -755.06M | -1B | -1.38B | -1.88B | -2.34B | -3.01B | -3.43B | -3.82B | -3.88B |
| Treasury Stock | 0 | 0 | 0 | -22.99M | -34.97M | -40.86M | -40.86M | -5.89M | -5.89M |
| Accumulated OCI | 64.87M | 47.55M | 67.07M | 76.44M | 62.91M | 59.37M | 75.59M | 72.51M | 74.36M |
| Minority Interest | 2.19M | 1.44M | -512K | -2.73M | 973.24M | 1.02B | 1.06B | 859.55M | 1.02B |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -388.65M | -204.37M | -343.02M | -510.19M | -116.78M | -688.84M | -23.15M | -447.24M | 263.02M |
| Operating CF Margin % | -0.44% | -0.21% | -0.19% | -0.13% | -0.01% | -0.06% | -0% | -0.03% | 0.02% |
| Operating CF Growth % | - | 0.47% | -0.68% | -0.49% | 0.77% | -4.9% | 0.97% | -18.32% | 1.59% |
| Net Income | -363.45M | -249.33M | -382.04M | -501.83M | -456.53M | -621.02M | -376.07M | -353.43M | -20.78M |
| Depreciation & Amortization | 12.06M | 14.82M | 11.27M | 11.67M | 14.02M | 27.22M | 40.82M | 21.78M | 16.97M |
| Stock-Based Compensation | 3.44M | 9.92M | 51.36M | 54.28M | 75.69M | 145.59M | 162.07M | 226.69M | 20.15M |
| Deferred Taxes | 0 | 0 | 1.95M | 3.55M | -89.71M | 86.36M | 0 | 0 | 0 |
| Other Non-Cash Items | 22K | -10K | -11.71M | 25.39M | 334.79M | 42.88M | 105.56M | 82.05M | 54.01M |
| Working Capital Changes | -40.72M | 20.22M | -13.84M | -103.26M | 4.97M | -369.87M | 44.46M | -424.33M | 192.66M |
| Change in Receivables | 1.98M | 7.99M | -8.17M | -36.68M | -98.28M | -242.4M | -86.98M | -49.9M | 121.97M |
| Change in Inventory | -22.03M | -9.32M | -66.78M | -276.23M | 24.22M | -400.55M | -406.29M | 59.59M | 28.11M |
| Change in Payables | 8.94M | 30.16M | 84.12M | 232.08M | 629.02M | 274M | 417.5M | -176.74M | 132.73M |
| Cash from Investing | -267.55M | -36.13M | 44.45M | 237.53M | -324.67M | 60.14M | -47.17M | 151.74M | 37.38M |
| Capital Expenditures | -6.92M | -6.86M | -14.82M | -24.61M | -25.5M | -62.69M | -31.57M | -9.82M | -15.2M |
| CapEx % of Revenue | 0.01% | 0.01% | 0.01% | 0.01% | 0% | 0.01% | 0% | 0% | 0% |
| Acquisitions | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | -1.3M | -5K | -275K | -4.55M | -324.67M | 216K | -2.99M | 1.65M | 458K |
| Cash from Financing | 148.42M | 49.5M | 972.7M | 106.95M | 1.07B | 74.34M | 22.73M | 205.98M | -406.24M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - |
| Other Financing | 195.92M | 49.5M | 0 | 34.86M | 941.89M | 49.82M | 103.13M | 36.25M | -229.16M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -395.57M | -211.23M | -357.84M | -534.8M | -142.28M | -751.53M | -54.73M | -457.07M | 247.82M |
| FCF Margin % | -0.45% | -0.22% | -0.2% | -0.14% | -0.02% | -0.06% | -0% | -0.03% | 0.02% |
| FCF Growth % | - | 0.47% | -0.69% | -0.49% | 0.73% | -4.28% | 0.93% | -7.35% | 1.54% |
| FCF per Share | -109.88 | -58.68 | -71.96 | -65.35 | -17.27 | -90.62 | -6.57 | -54.22 | 28.76 |
| FCF Conversion (FCF/Net Income) | 1.07x | 0.82x | 0.90x | 1.02x | 0.26x | 1.03x | 0.06x | 1.14x | -4.06x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10.42M | 6.16M |
| Taxes Paid | 0 | 0 | 8K | 0 | 0 | 0 | 0 | 251K | 96K |
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -63.02% | -55.59% | -49.28% | -50.24% | -43.38% | -61.47% | -55.7% | -84.97% | -19.71% |
| Return on Invested Capital (ROIC) | -135.24% | -107.89% | -115.23% | -100.18% | -84.59% | -83.85% | -55.81% | -120.84% | 1.09% |
| Gross Margin | 8.88% | 9.46% | 5.84% | 4.18% | 4.46% | 5% | 6.21% | 3% | 5.76% |
| Net Margin | -41.5% | -25.91% | -21.28% | -12.7% | -5.57% | -5.39% | -3.08% | -2.63% | -0.45% |
| Debt / Equity | - | - | - | 0.27x | 0.25x | 0.58x | 0.53x | 1.61x | 0.67x |
| Interest Coverage | -485.06x | -4618.58x | - | -136.25x | -53.68x | -117.01x | -27.60x | -17.38x | 0.07x |
| FCF Conversion | 1.07x | 0.82x | 0.90x | 1.02x | 0.26x | 1.03x | 0.06x | 1.14x | -4.06x |
| Revenue Growth | - | 9.8% | 86.14% | 121.28% | 107.57% | 51.48% | 8.78% | 10.59% | -3.66% |
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Product | 1.77B | 3.93B | 8.16B | 12.33B | 13.4B | 14.84B | 14.29B |
| Product Growth | - | 121.99% | 107.56% | 51.19% | 8.69% | 10.73% | -3.69% |
| Drugs | 1.49B | 3.6B | 7.4B | 11.68B | 12.57B | 13.88B | 13.4B |
| Drugs Growth | - | 141.32% | 105.77% | 57.89% | 7.63% | 10.42% | -3.49% |
| Nutritional Supplements | 190.43M | 245.64M | 559.24M | - | 554.79M | 631.12M | 550.46M |
| Nutritional Supplements Growth | - | 29.00% | 127.66% | - | - | 13.76% | -12.78% |
| Other Products | 16.03M | 20.35M | 46.53M | - | 111.1M | 170.23M | 201.83M |
| Other Products Growth | - | 26.95% | 128.68% | - | - | 53.23% | 18.56% |
| Medical Supplies And Devices | 26.56M | 50.18M | 149.05M | - | 164.92M | 157.5M | 144.28M |
| Medical Supplies And Devices Growth | - | 88.90% | 197.04% | - | - | -4.49% | -8.39% |
| Service | 15.74M | 22.36M | 46.48M | 94.2M | 113.26M | 106.22M | 106.51M |
| Service Growth | - | 42.00% | 107.94% | 102.64% | 20.24% | -6.22% | 0.27% |
| MP Service | - | - | - | 52.31M | 68.48M | 70.27M | 65.54M |
| MP Service Growth | - | - | - | - | 30.91% | 2.62% | -6.74% |
| Service, Other | - | - | - | - | 44.78M | 35.95M | 40.97M |
| Service, Other Growth | - | - | - | - | - | -19.73% | 13.98% |
| Nutritional supplements | - | - | - | 442.5M | - | - | - |
| Nutritional supplements Growth | - | - | - | - | - | - | - |
| Medical supplies and devices | - | - | - | 124.92M | - | - | - |
| Medical supplies and devices Growth | - | - | - | - | - | - | - |
| Other products. | - | - | - | 83.14M | - | - | - |
| Other products. Growth | - | - | - | - | - | - | - |
| Other Services | - | - | - | 41.89M | - | - | - |
| Other Services Growth | - | - | - | - | - | - | - |
| Contact lenses. | - | - | - | 38K | - | - | - |
| Contact lenses. Growth | - | - | - | - | - | - | - |
| Mp Service | 12.38M | 17.24M | 30.53M | - | - | - | - |
| Mp Service Growth | - | 39.31% | 77.12% | - | - | - | - |
| Service Other | 3.37M | 5.12M | 15.95M | - | - | - | - |
| Service Other Growth | - | 51.90% | 211.81% | - | - | - | - |
| Contact Lenses | 47.3M | 18.11M | 3.42M | - | - | - | - |
| Contact Lenses Growth | - | -61.71% | -81.12% | - | - | - | - |
111, Inc. (YI) reported $14.18B in revenue for fiscal year 2024. This represents a 1523% increase from $873.8M in 2016.
111, Inc. (YI) saw revenue decline by 3.7% over the past year.
111, Inc. (YI) reported a net loss of $74.1M for fiscal year 2024.
111, Inc. (YI) has a return on equity (ROE) of -19.7%. Negative ROE indicates the company is unprofitable.
111, Inc. (YI) generated $97.3M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.